Skip to content
Screener

Common Stock at other companies

Opus Genetics logo
Opus GeneticsIRD
125M0.0%
Regenxbio logo
RegenxbioRGNX
$5K0.0%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$211K+25.6%
Prime Medicine logo
Prime MedicinePRME
775M0.0%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$5K0.0%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
15.8B0.0%

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.18B+85.4%
Enterprise value$1.18B+71.1%
P/S14.9×-2.0×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 8:30 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-060739
Line itemMarch 31, 2026December 31, 2025
TOTAL LIABILITIES302,785250,223
COMMITMENTS AND CONTINGENCIES (Note 12)
SHAREHOLDERS' DEFICIT:
Ordinary Shares, $0.00003881 par value, 1,288,327,750 authorized, 81,446,126 and 81,120,931 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively33
Capital in excess of par value820,018808,021
Treasury shares(18,193)
Accumulated other comprehensive gain2,5782,406
Accumulated deficit(862,536)(816,223)

Item 1. Financial Statements (Unaudited)

FAQ

What is MeiraGTx Holdings plc's common stock?
MeiraGTx Holdings plc (MGTX) reported common stock of $3K in Q1 2026.
How has MeiraGTx Holdings plc's common stock changed year-over-year?
MeiraGTx Holdings plc's common stock decreased by 0.0% year-over-year, from $3K to $3K.
What is the long-term trend for MeiraGTx Holdings plc's common stock?
Over 5 years (2020 to 2025), MeiraGTx Holdings plc's common stock has grown at a 8.4% compound annual growth rate (CAGR), from $2K to $3K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about MeiraGTx Holdings plc's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude